Today's AI Developments: Policy Shifts, Biotech Breakthroughs, and Platform Changes
Here's a roundup of today's top artificial intelligence stories spanning policy, healthcare, and consumer platforms.
Fed Chair Kevin Warsh Consults Tech Leaders on AI Policy
Federal Reserve Chair Kevin Warsh is consulting with technology industry leaders, including venture capitalist Marc Andreessen and Xbox CEO Asha Sharma, to help inform future monetary policy related to artificial intelligence and emerging technologies.
Insilico Medicine Projects Profit as AI-Developed Drug Advances to Phase III
Insilico Medicine has announced projections of profit and significant revenue increases as its AI-developed lead drug candidate advances to Phase III clinical trials, marking a potential milestone for AI-assisted drug discovery.
OpenAI Safety Head Resigns Amid Executive Exodus
OpenAI's head of safety has resigned, continuing a pattern of executive departures from the company as it navigates the complexities of developing advanced AI systems.
Read more: OpenAI Safety Boss Resigns in Latest Executive Departure
Instagram Parent Meta to Charge for AI Features
Instagram's parent company Meta is reportedly planning to charge users for access to AI features, marking a shift in how social media platforms monetize artificial intelligence services.
Read more: Instagram will charge for AI access
ByteDance, Alibaba Disable AI Companions Under China's New Rules
ByteDance and Alibaba are disabling humanlike AI companion features in response to new Chinese government regulations targeting artificial intelligence products that simulate human interaction.
Read more: ByteDance, Alibaba to disable humanlike AI companions as China tightens rules
Global Consortium Launches AI Tools for Alzheimer's Research
A worldwide consortium has unveiled new AI tools designed to speed up Alzheimer's disease research and the development of new treatments, marking a collaborative effort to tackle one of neuroscience's most pressing challenges.
Read more: Global consortium launches AI tools to accelerate Alzheimer's research, treatments